Replimune Group Gestion
Gestion contrôle des critères 2/4
Le PDG Replimune Group est Sush Patel, nommé en Apr2024, a un mandat de moins d'un an. détient directement 0.074% des actions de la société, d'une valeur de $ 751.70K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.2 ans et 6.4 ans.
Informations clés
Sush Patel
Directeur général
n/a
Rémunération totale
Pourcentage du salaire du PDG | n/a |
Durée du mandat du directeur général | less than a year |
Propriété du PDG | 0.07% |
Durée moyenne d'occupation des postes de direction | 1.2yrs |
Durée moyenne du mandat des membres du conseil d'administration | 6.4yrs |
Mises à jour récentes de la gestion
Recent updates
Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Nov 23Replimune: Strong Data In A Highly Differentiated Space
Sep 03Is Replimune Group (NASDAQ:REPL) Using Debt Sensibly?
Aug 16Replimune: Continuing To Justify The Bear Thesis (For Now)
May 22Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Feb 06Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer
Jan 23Calculating The Intrinsic Value Of Replimune Group, Inc. (NASDAQ:REPL)
Dec 25Is Replimune Group (NASDAQ:REPL) A Risky Investment?
Jul 13Is Replimune Group (NASDAQ:REPL) Using Debt In A Risky Way?
Apr 05A Look At The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Jan 06Replimune secures $200M term loan
Oct 07Replimune: Recent Developments Strengthen Bull Thesis
Aug 12Replimune Group (NASDAQ:REPL) Has Debt But No Earnings; Should You Worry?
Aug 06Replimune Group GAAP EPS of -$0.78 misses by $0.15
Aug 04Replimune Group, Inc. (NASDAQ:REPL) Shares Could Be 23% Below Their Intrinsic Value Estimate
Jun 24We're Not Very Worried About Replimune Group's (NASDAQ:REPL) Cash Burn Rate
Apr 04Companies Like Replimune Group (NASDAQ:REPL) Are In A Position To Invest In Growth
Dec 16Replimune: In The 'Buy Zone' Again
Oct 01Estimating The Fair Value Of Replimune Group, Inc. (NASDAQ:REPL)
Sep 02Replimune Group (NASDAQ:REPL) Is In A Strong Position To Grow Its Business
May 24Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic
Apr 30We're Interested To See How Replimune Group (NASDAQ:REPL) Uses Its Cash Hoard To Grow
Feb 08Replimune Group EPS misses by $0.03
Feb 04Dosing underway in Replimune's early-stage cancer study with gene therapy
Jan 05Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$213m |
Jun 30 2024 | n/a | n/a | -US$220m |
Mar 31 2024 | n/a | n/a | -US$216m |
Dec 31 2023 | n/a | n/a | -US$210m |
Sep 30 2023 | n/a | n/a | -US$199m |
Jun 30 2023 | n/a | n/a | -US$182m |
Mar 31 2023 | US$3m | US$447k | -US$174m |
Dec 31 2022 | n/a | n/a | -US$157m |
Sep 30 2022 | n/a | n/a | -US$147m |
Jun 30 2022 | n/a | n/a | -US$133m |
Mar 31 2022 | US$7m | US$394k | -US$118m |
Rémunération vs marché: Données insuffisantes pour établir si la rémunération totale de Sush est raisonnable par rapport à des entreprises de taille similaire sur le marché US.
Rémunération et revenus: La rémunération de Sush a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Sush Patel (53 yo)
less than a year
Titularisation
US$2,595,003
Compensation
Dr. Sushil Patel, also known as Sush,Ph D, is CEO & Director of Replimune Group, Inc. from April 1, 2024. Dr. Patel served as the Chief Commercial Officer at Replimune Group, Inc. since May 3, 2021 and ser...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Executive Chairman | 9.8yrs | US$6.02m | 1.86% $ 19.0m | |
Chief Financial Officer | 1.2yrs | US$3.61m | 0.017% $ 177.5k | |
Chief Medical Officer | 1.9yrs | US$2.45m | 0.017% $ 169.4k | |
CEO & Director | less than a year | US$2.60m | 0.074% $ 751.7k | |
Founder | no data | US$5.72m | 2.57% $ 26.2m | |
Chief Accounting Officer & Treasurer | 1.5yrs | pas de données | 0.010% $ 104.8k | |
Chief Commercial Officer | 1.9yrs | pas de données | 0.017% $ 177.7k | |
Chief Manufacturing Officer & Framingham Site Head | less than a year | pas de données | pas de données |
1.2yrs
Durée moyenne de l'emploi
53yo
Âge moyen
Gestion expérimentée: L'équipe de direction de REPL n'est pas considérée comme expérimentée (ancienneté moyenne 1.2 ans), ce qui suggère une nouvelle équipe.
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Executive Chairman | 9.8yrs | US$6.02m | 1.86% $ 19.0m | |
CEO & Director | less than a year | US$2.60m | 0.074% $ 751.7k | |
Founder | 9.8yrs | US$5.72m | 2.57% $ 26.2m | |
Independent Director | 7.1yrs | US$362.60k | 0.0097% $ 99.5k | |
Independent Non-Executive Director | 6.5yrs | US$355.10k | 0% $ 0 | |
Independent Director | 4.6yrs | US$360.10k | 0% $ 0 | |
Director | less than a year | pas de données | pas de données | |
Independent Director | 7.3yrs | US$357.60k | 0% $ 0 | |
Independent Director | 2.9yrs | US$352.60k | 0% $ 0 | |
Lead Independent Director | 6.4yrs | US$516.81k | 0% $ 0 | |
Independent Director | 1.4yrs | US$667.97k | 0% $ 0 |
6.4yrs
Durée moyenne de l'emploi
59yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de REPL sont considérés comme expérimentés (ancienneté moyenne 6.4 ans).